Moreover, after activated by HPV+ tumor cells, CD4_C3_CXCL13 T cells were significantly enriched in HPV+ OPSCC and have been associated with a favorable prognosis, underscoring their potential as a prognostic biomarker [13]. This evidence concerns the gene CXCL13 and neoplasm.